Sarepta Pharmaceuticals, The Scripps Research Institute (2014) Oligonucleotide compound and method for treating nidovirus infections. . (USOO8759307B2)
Abstract/Summary
A method and oligonucleotide compound for inhibiting replication of a nidovirus in virus-infected animal cells are disclosed. The compound (i) has a nuclease-resistant backbone, (ii) is capable of uptake by the infected cells, (iii) contains between 8-25 nucleotide bases, and (iv) has a sequence capable of disrupting base pairing between the transcriptional regulatory sequences in the 5′ leader region of the positive-strand viral genome and negative-strand 3′ subgenomic region. In practicing the method, infected cells are exposed to the compound in an amount effective to inhibit viral replication.
| Additional Information | US Patent 8,759,307 |
| Item Type | Patent |
| URI | https://reading-clone.eprints-hosting.org/id/eprint/37088 |
| Divisions | Life Sciences > School of Biological Sciences > Biomedical Sciences |
| Additional Information | US Patent 8,759,307 |
| Publisher | Google Patents |
| Download/View statistics | View download statistics for this item |
Downloads
Downloads per month over past year
University Staff: Request a correction | Centaur Editors: Update this record
Download
Download